TESTING PANELS

 

Drug Response Panel (83 genes)

The Drug Response Panel is a comprehensive next-generation sequencing (NGS) panel that can be used to determine a patient’s response to various drugs based on their genotype, which can assist in determining optimal dosing and reducing adverse events.

The Drug Response Panel covers hundreds of the most commonly prescribed drugs across of a large cross section of therapeutic areas. Genetic factors account for 20% to 95% of variability in response to individual drugs (Kalow et al, 1998) and 10% to 20% of adverse drug reactions may be related to genetic factors (Ingelman-Sundberg, 2004). Therefore, pharmacogenomic testing can reduce adverse drug reactions, help optimize dosing, and assist in selecting the most effective medication.